Delivery Order SPE2DB20D2014-SPE2DB23FC84V

Award Date 7/25/23
Potential Completion Date 7/26/23
Potential Value $37
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a delivery order valued at $331.80 to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. The firm fixed price order is for 3.5 grams of the ophthalmic product and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania by June 27, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any broader indefinite delivery/indefinite quantity contracts...
The Defense Logistics Agency awarded a $33,180 delivery order to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. The firm fixed price order is for 3.5 grams of the ophthalmic product and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania by August 18, 2023. No subcontractors or set aside designations were identified. The DLA manages the Department of Defense's global logistics operations and procurement programs, and this small order for a...
The Defense Logistics Agency awarded a $143,040 delivery order to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. The firm fixed price order is for 3.5 gram units of the ophthalmic medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over the period of June 27-28, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the global supply chain for the United States Department...
The Defense Logistics Agency awarded a $47,500 delivery order to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. The firm fixed price order is for 3.5 grams of the ophthalmic medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania. Performance will take place from August 16 to August 17, 2023. As the DLA supports all branches of the U.S. military, this order for an antibiotic ointment will likely provide needed medical supplies...
The Defense Logistics Agency awarded a $28,500 delivery order to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. The firm fixed price order is for 3.5 grams of the ophthalmic product and will be performed in Conshohocken, Pennsylvania between June 27-28, 2023. As a major component of the Department of Defense supply chain, the DLA supports military readiness by procuring and delivering medical supplies to armed forces personnel worldwide. Amerisourcebergen, operating...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at fifty-seven thousand dollars to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. Under this contract, Amerisourcebergen will deliver approximately three and a half grams of the ointment to a location in Conshohocken, Pennsylvania by July 12, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The Defense...
The Defense Logistics Agency awarded a delivery order valued at one hundred seventy thousand six hundred sixty-four dollars to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. Under this firm fixed price contract, Amerisourcebergen will deliver 3.5 gram tubes of the ointment to a location in Conshohocken, Pennsylvania by August eighteenth, twenty twenty-three in support of Department of Defense requirements. No set aside designation or subcontractors were identified. This...
The Defense Logistics Agency awarded a $47,500 delivery order to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. The firm fixed price order is for 3.5 grams of the ophthalmic medication and will be fulfilled by Amerisourcebergen from its facility in Conshohocken, Pennsylvania. Performance will take place between August 6-7, 2023. No set aside designation or subcontractors were identified. The DLA manages the Department of Defense's global logistics operations and supply...
The Defense Logistics Agency awarded a $113,760 delivery order to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. The firm fixed price order is for 3.5 gram units of the ophthalmic product and will be performed in Conshohocken, Pennsylvania between June 27-28, 2023. As a major component of the Department of Defense supply chain, the DLA supports military readiness by procuring and delivering medical supplies through various contracting vehicles. This small order for a...
The Defense Logistics Agency awarded a $142,200 delivery order to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. The firm fixed price order is for 3.5 gram units of the ophthalmic medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. No set aside designation or subcontractors were identified. The DLA procures pharmaceuticals and medical supplies to support the Department of Defense's...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB23FC84V
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-six thousand five hundred forty dollars to Amerisourcebergen Drug Corporation for erythromycin 0.5% eye ointment. Under this contract, Amerisourcebergen will deliver approximately three and a half grams of the ointment to a location in Conshohocken, Pennsylvania by July 26, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA medical product supply vehicle and will help the agency meet short-term requirements for this pharmaceutical to treat bacterial eye infections.

Generated 12/21/23, 9:56 PM